Roivant Sciences Ltd. (ROIV)

35.72 +0.22 (+0.62%) USD  |  NASDAQ  |  Oct 02, 16:00
35.68 -0.04 (-0.11%) After-Hours: 20:00
More

Roivant Sciences EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ROIV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2023. Start Trial.
Date Value
February 13, 2024 --
Date Value
December 11, 2023 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Oxford Biomedica Plc --
Bicycle Therapeutics Plc --
Arbutus Biopharma Corp. --
Adaptimmune Therapeutics Plc --
Kiniksa Pharmaceuticals International Plc Upgrade